Drug injection device for skin treatment
By designing a drug injection device containing a protective case and a regulating mechanism, using an extrusion rod and a battery to drive fat cell death, the problems of high operation difficulty, high cost and needle cross-infection in the prior art are solved, and low cost is achieved. Effective skin treatment effect.
Patent Information
- Application Number
- CN202322350310.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2023-08-31
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2033-08-31
AI Technical Summary
The existing skin treatment technology is difficult to operate, expensive, and has the risk of needle cross infection and bacterial infection.
A drug injection device including a protective case, a spiral top cover, an injection mechanism and a regulation mechanism is designed to inject saline and apply electric potential through the battery to drive fat cell death by extruding a combination of a rod, an injection rod, a piston and a needle. Alternate use and storage of needles is achieved through a regulatory mechanism to avoid cross-infection and bacterial infection.
It reduces the difficulty of operation and cost of use, avoids needle cross infection and bacterial infection, and achieves low-cost and efficient skin treatment effects.
Smart Images

Figure CN222056140U_ABST
Abstract
Description
Technical Field
[0001] The utility model belongs to the technical field of medical appliances, and in particular relates to a drug injection device for skin treatment. Background Art
[0002] Body contouring achieved through subcutaneous adipose tissue reduction has evolved significantly over the past century, from suction-assisted lipectomy to less invasive techniques including laser, radiofrequency, high-frequency focused ultrasound, cryolipolysis, and drug-based injection approaches that are expensive and focus on disrupting the adipocyte membrane, hydrolyzing triglycerides (TG), or inducing apoptosis.
[0003] For example, in Chinese patent application number CN201520720438.7, a semi-automatic lipoma removal system is provided, which can directly perform disinfection and treatment without the need to inject drugs into the patient's body through an injection needle. This can save surgical time and is easy to operate, with obvious treatment effects. In addition, the blade and the connecting column are snap-fitted, and the blade can be replaced as needed.
[0004] However, this technology requires the use of expensive instruments and drugs, is difficult to operate, and has high cost. Therefore, we propose a drug injection device for skin treatment. Utility Model Content
[0005] The technical problem to be solved by the utility model is to overcome the deficiencies of the prior art and provide a drug injection device for skin treatment that can overcome the above problems or at least partially solve the above problems.
[0006] In order to solve the above technical problems, the basic concept of the technical solution adopted by the utility model is: a drug injection device for skin treatment, including a protective shell and a top cover spirally arranged on the top of the protective shell, and also including:
[0007] An injection mechanism, the injection mechanism is used to inject physiological saline into the skin;
[0008] The adjusting mechanism is used to fold up the injection mechanism when the injection mechanism is not in use.
[0009] Furthermore, the injection mechanism includes a connecting plate slidably arranged in the protective shell, the connecting plate is fixed to the bottom of the top cover by a connecting rod, an extrusion rod is slid in the connecting plate, the top end of the extrusion rod slides through the top cover and extends to the top of the top cover, the bottom end of the extrusion rod is fixed with a connecting strip, a mounting plate is provided below the connecting strip, an injection barrel is fixed to the bottom of the mounting plate, an injection rod is fixed to the bottom of the connecting strip, the injection rod slides through the top wall of the injection barrel, a piston is fixed to the bottom end of the injection rod, the piston moves in the injection barrel, the bottom of the injection barrel is connected to a needle, and a pressing head is fixed to the top of the extrusion rod.
[0010] Furthermore, the number of the syringes and needles in each row is two, the two needles correspond to the positive and negative poles of the electrodes respectively, and a battery is detachably mounted on the outer surface of the protective shell, and the battery is electrically connected to the two needles.
[0011] Furthermore, the adjustment mechanism includes a support block fixed on the side of the mounting plate, a slide rod is fixed on the top of the support block, the slide rod slides through the connecting plate and the top cover, a spring limit block is sleeved on the outer surface of the slide rod, and a rectangular block is fixed on the top of the slide rod.
[0012] Furthermore, the adjustment mechanism also includes a fixing block fixed to the top of the top cover, a slot is provided on the top of the fixing block, a fixing block is fixed to the bottom of the rectangular block, and the fixing block is connected to the slot.
[0013] Furthermore, the syringe and the needle are both located in the protective shell when not in use.
[0014] Furthermore, a protective cover is provided at the bottom of the protective shell, and the protective cover is threadedly connected to the bottom of the protective shell.
[0015] Furthermore, the battery can be fixedly connected to the protective shell by bolts.
[0016] After adopting the above technical scheme, the utility model has the following beneficial effects compared with the prior art: through the setting of the connecting plate, the extrusion rod, the connecting strip, the mounting plate, the injection barrel, the injection rod, the piston and the needle, it is used to inject saline, and the saline is injected into the subcutaneous fat tissue. Through the setting of the storage battery, the two needles are energized and an electric potential is applied. The electrolysis of the saline produces a local pH gradient, which drives the death of fat cells and the saponification of TG. The pH map, various optical imaging techniques and biochemical assays are used to induce acid and alkali damage. The use cost is low and the operation difficulty is small. Through the setting of the adjustment mechanism, the needles can be used alternately to avoid cross infection caused by repeated use of needles. By adjusting the position of the needles, when one group of needles is in use, the other group can be put away to avoid mutual influence. After use, the needles can be put into the protective shell for protection to avoid bacterial infection of the protective shell.
[0017] The specific implementation of the utility model is further described in detail below with reference to the accompanying drawings. BRIEF DESCRIPTION OF THE DRAWINGS
[0018] In the attached picture:
[0019] Figure 1 This is a schematic diagram of the structure of a drug injection device for skin treatment proposed by the utility model;
[0020] Figure 2 The utility model provides a drug injection device for skin treatment Figure 1 A schematic diagram of the structure enlargement in the middle;
[0021] Figure 3 This is a front view schematic diagram of a protective shell structure in a drug injection device for skin treatment proposed by the utility model;
[0022] Figure 4 This is a schematic cross-sectional view of a protective shell structure in a drug injection device for skin treatment proposed by the utility model;
[0023] Figure 5 The utility model is a schematic side view of a cross-section of a protective shell structure in a drug injection device for skin treatment proposed by the utility model.
[0024] In the figure: 1. protective shell; 2. top cover; 3. injection mechanism; 4. adjustment mechanism; 31. connecting plate; 32. extrusion rod; 33. connecting strip; 34. mounting plate; 35. injection cylinder; 36. injection rod; 37. piston; 38. needle; 39. battery; 310. pressing head; 41. supporting block; 42. sliding rod; 43. spring limit block; 44. rectangular block; 45. fixing block; 46. slot; 47. block. DETAILED DESCRIPTION
[0025] In order to make the purpose, technical solutions and advantages of the embodiments of the utility model clearer, the technical solutions in the embodiments will be clearly and completely described below in conjunction with the drawings in the embodiments of the utility model. The following embodiments are used to illustrate the utility model but are not used to limit the scope of the utility model.
[0026] Embodiment 1:
[0027] Reference Figure 1-Figure 5 , a drug injection device for skin treatment, comprising a protective shell 1 and a top cover 2 spirally arranged on the top of the protective shell 1, and also comprising:
[0028] An injection mechanism 3, the injection mechanism 3 is used to inject physiological saline into the skin;
[0029] The adjusting mechanism 4 is used to fold up the injection mechanism 3 when the injection mechanism 3 is not in use.
[0030] Among them, the injection mechanism 3 includes a connecting plate 31 slidably arranged in the protective shell 1, and the connecting plate 31 is fixed to the bottom of the top cover 2 through a connecting rod. An extrusion rod 32 slides in the connecting plate 31, and the top end of the extrusion rod 32 slides through the top cover 2 and extends to the top of the top cover 2. A connecting strip 33 is fixed to the bottom end of the extrusion rod 32, and a mounting plate 34 is provided below the connecting strip 33. A syringe 35 is fixed to the bottom of the mounting plate 34, and an injection rod 36 is fixed to the bottom of the connecting strip 33. The injection rod 36 slides through the top wall of the syringe 35, and a piston 37 is fixed to the bottom end of the injection rod 36. The piston 37 moves in the syringe 35, and the bottom of the syringe 35 is connected to a needle 38. A pressing head 310 is fixed to the top of the extrusion rod 32.
[0031] There are two syringes 35 and needles 38 in each row, and the two needles 38 correspond to the positive and negative poles of the electrode respectively. A battery 39 is detachably mounted on the outer surface of the protective shell 1 , and the battery 39 is electrically connected to the two needles 38 .
[0032] The battery 39 can be fixedly connected to the protective shell 1 by bolts.
[0033] Specifically, by setting the squeezing rod 32, the squeezing rod 32 moves upward, thereby driving the connecting strip 33 and the injection rod 36 to move upward, and the injection rod 36 drives the piston 37 to move upward in the injection barrel 35. Through pressure, physiological saline can be sucked into the injection barrel 35 from the needle 38. When in use, the two needles 38 are inserted into the human skin, and by pressing the pressing head 310, the squeezing rod 32 and the connecting strip 33 are driven to move downward, and the connecting strip 33 drives the piston 37 to move downward, squeezing the saline, so that the saline is injected into the human skin. The two needles 38 are electrically connected through a battery 39. Since the two needles 38 correspond to the positive and negative electrodes respectively, the two needles 38 are energized through the battery 39 and an electric potential is applied. The electrolysis of the saline produces a local pH gradient, which drives the death of fat cells and the saponification of TG. A pH map, various optical imaging techniques and biochemical assays are used to induce acid and alkali damage. This solution does not require the use of expensive instruments and drugs, has a low cost of use, and is easy to operate. The battery 39 is fixed to the protective shell 1 by bolts, and the battery 39 can be removed by tightening the bolts.
[0034] Embodiment 2:
[0035] Reference Figure 1-Figure 5 , a drug injection device for skin treatment, comprising a protective shell 1 and a top cover 2 spirally arranged on the top of the protective shell 1, and also comprising:
[0036] An injection mechanism 3, the injection mechanism 3 is used to inject physiological saline into the skin;
[0037] The adjusting mechanism 4 is used to fold up the injection mechanism 3 when the injection mechanism 3 is not in use.
[0038] The adjustment mechanism 4 includes a support block 41 fixed to the side of the mounting plate 34, a slide rod 42 is fixed to the top of the support block 41, the slide rod 42 slides through the connecting plate 31 and the top cover 2, a spring limit block 43 is sleeved on the outer surface of the slide rod 42, and a rectangular block 44 is fixed to the top of the slide rod 42.
[0039] The adjustment mechanism 4 further includes a fixing block 45 fixed to the top of the top cover 2 . A slot 46 is formed on the top of the fixing block 45 . A block 47 is fixed to the bottom of the rectangular block 44 . The block 47 is engaged in the slot 46 .
[0040] The syringe 35 and the needle 38 are both located in the protective shell 1 when not in use.
[0041] A protective cover is provided at the bottom of the protective shell 1 , and the protective cover is threadedly connected to the bottom of the protective shell 1 .
[0042] The same as Example 1, furthermore:
[0043] Specifically, by setting up multiple groups of needles 38, after the needles 38 in the first row are used up, the needles 38 in the second row can be used continuously, so that the needles 38 can be used alternately to avoid cross infection caused by repeated use of the needles 38. When the needles 38 in the first row are used, the rectangular block 44 can be pulled upward, the rectangular block 44 drives the slide bar 42 to move upward, the slide bar 42 drives the mounting plate 34 to move upward, the mounting plate 34 drives the syringe 35 and the needles 38 to move upward, so that the needles 38 in the second row are stored in the protective shell 1, and by rotating the slide bar 42, the rectangular block 44 can be pulled upward to drive the slide bar 42 to move upward, and the mounting plate 34 drives the syringe 35 and the needles 38 to move upward, so that the needles 38 in the second row are stored in the protective shell 1. 44 corresponds to the position of the fixing block 45, that is, it is located just above the fixing block 45. At this time, the rectangular block 44 is loosened, and the elastic force of the spring limit block 43 is used to drive the rectangular block 44 and the clamping block 47 to move downward, so that the clamping block 47 is clamped into the clamping groove 46, and the position of the second row of syringes 35 is locked. This design allows one group of needles 38 to be put away when another group is in use to avoid mutual influence, and after use, the needles 38 can be put into the protective shell 1, and the bottom of the protective shell 1 is sealed by the protective cover for protection to prevent the protective shell 1 from being infected by bacteria.
[0044] The above description is only a preferred embodiment of the present invention and does not limit the present invention in any form. Although the present invention has been disclosed as a preferred embodiment, it is not intended to limit the present invention.
Claims
1. A drug injection device for skin treatment, comprising a protective shell (1) and a top cover (2) spirally arranged on the top of the protective shell (1), characterized in that: Also includes: An injection mechanism (3), the injection mechanism (3) being used to inject physiological saline into the skin; An adjusting mechanism (4), wherein the adjusting mechanism (4) is used to fold up the injection mechanism (3) when the injection mechanism (3) is not in use; The injection mechanism (3) comprises a connecting plate (31) slidably arranged in the protective shell (1), the connecting plate (31) being fixed to the bottom of the top cover (2) through a connecting rod, an extrusion rod (32) slidingly arranged in the connecting plate (31), the top end of the extrusion rod (32) slidingly passing through the top cover (2) and extending to the top of the top cover (2), a connecting strip (33) being fixedly arranged at the bottom end of the extrusion rod (32), and a mounting plate (34) being arranged below the connecting strip (33). The bottom of the mounting plate (34) is fixed with an injection cylinder (35), the bottom of the connecting strip (33) is fixed with an injection rod (36), the injection rod (36) slides through the top wall of the injection cylinder (35), a piston (37) is fixed at the bottom end of the injection rod (36), the piston (37) moves in the injection cylinder (35), the bottom of the injection cylinder (35) is connected with a needle (38), and a pressing head (310) is fixed at the top end of the extrusion rod (32); The adjustment mechanism (4) comprises a support block (41) fixed on the side of the mounting plate (34), a slide bar (42) is fixed on the top of the support block (41), the slide bar (42) slides through the connecting plate (31) and the top cover (2), a spring limit block (43) is sleeved on the outer surface of the slide bar (42), and a rectangular block (44) is fixed on the top of the slide bar (42).
2. The drug injection device for skin treatment according to claim 1, characterized in that: The number of the injection barrels (35) and needles (38) in each row is two, and the two needles (38) correspond to the positive and negative poles of the electrode respectively. A battery (39) is detachably mounted on the outer surface of the protective shell (1), and the battery (39) is electrically connected to the two needles (38).
3. The drug injection device for skin treatment according to claim 1, characterized in that: The adjustment mechanism (4) further comprises a fixing block (45) fixed on the top of the top cover (2), a clamping slot (46) being provided on the top of the fixing block (45), a clamping block (47) being fixed on the bottom of the rectangular block (44), and the clamping block (47) being clamped in the clamping slot (46).
4. The drug injection device for skin treatment according to claim 1, characterized in that: When not in use, the syringe barrel (35) and the needle (38) are both located inside the protective shell (1).
5. The drug injection device for skin treatment according to claim 1, characterized in that: A protective cover is provided at the bottom of the protective shell (1), and the protective cover is threadedly connected to the bottom of the protective shell (1).
6. The drug injection device for skin treatment according to claim 2, characterized in that: The storage battery (39) can be fixedly connected to the protective shell (1) by means of bolts.
